Holen Sie sich die Stockscreener-App
2.15
1.38%
-0.03
Schlusskurs vom Vortag:
$2.18
Offen:
$2.18
24-Stunden-Volumen:
58,344
Relative Volume:
1.17
Marktkapitalisierung:
$19.58M
Einnahmen:
$9.19M
Nettoeinkommen (Verlust:
$-6.94M
KGV:
-2.5851
EPS:
-0.8317
Netto-Cashflow:
$-7.57M
1W Leistung:
+17.49%
1M Leistung:
-0.46%
6M Leistung:
-47.30%
1J Leistung:
-52.30%
1-Tages-Spanne:
$2.15
$2.3099
1-Wochen-Bereich:
$1.75
$2.37
52-Wochen-Spanne:
$1.4231
$6.96
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Firmenname
Neuroone Medical Technologies Corp
Sektor
Branche
Telefon
(952) 426-1383
Adresse
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.29 | 2.99B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.72 | 401.38M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.98 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
4.81 | 314.59M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.83 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-29 | Herabstufung | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
JonesTrading Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $8 - Moomoo
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Cal - GuruFocus
NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia
Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView
Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView
NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan
NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens - TradingKey
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time - Yahoo Finance
NeuroOne Medical Technologies Corp - tradingkey.com
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform - Yahoo Finance
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Cash Flow - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NMTC|NeuroOne Medical Technologies Corp|Price:1.900|Chg%:+0.050 - TradingKey
NMTC|NeuroOne Medical Technologies Corp|Price:1.630|Chg%:+0.080 - TradingKey
NeuroOne Medical Technologies (NMTC) Q2 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage Continues - dars.gov.et
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial - Yahoo Finance
Brian and Barbara Pratt disclose 12.5% NeuroOne stake (NASDAQ: NMTC) - Stock Titan
NeuroOne Medical Technologies (NMTC) Brian Pratt reports 1,085,934 shares - Stock Titan
Insider Sell: Mark Christianson Sells 10,000 Shares of NeuroOne Medical Technologies Corp (NMTC) - GuruFocus
NMTC (NMTC) director sells 10,000 shares, retains 20,692 after trade - Stock Titan
NeuroOne Medical Technologies Corp. Hits New 52-Week Low at $2.93 - MarketsMojo
Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June - Investing.com UK
NeuroOne Medical Technologies (NMTC) Weighs on Support After 4.58% DeclineSign of Strength - dars.gov.et
Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June By Investing.com - Investing.com South Africa
[144] NEUROONE MEDICAL TECHNOLOGIES Corp SEC Filing - Stock Titan
NeuroOne(R) Added to Russell Microcap(R) Index - Yahoo Finance
Form DEF 14A Neuroone Medical Technologies Corp For: 26 June By Investing.com - Investing.com South Africa
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
NMTC Should I Buy - Intellectia AI
NeuroOne Medical Technologies Corp. Hits 52-Week Low at $3.16 Amid Challenges - MarketsMojo
NeuroOne Medical Technologies Corp (NMTC) Institutional Confidence - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index - Yahoo Finance
NeuroOne Medical Technologies 10-Q/A Restatement for Q2 2026 – Financial Statement Corrections and Impact - Minichart
NeuroOne Medical Technologies Corporation Files Form 8-K Current Report with NASDAQ Listing Information - Minichart
NeuroOne Medical Technologies updates at-the-market offering for up to $13.4 million - Investing.com
NeuroOne to sell up to $13.4M in common stock through updated ATM prospectus - TradingView
Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):